FDA Approval of Dupilumab for Uncontrolled COPD will Change the Treatment Landscape: Interview with Surya Bhatt, MD, MSPH
Surya Bhatt, MD, MSPH, is coprincipal investigator for the 2 pivotal phase 3 clinical trials that supported today's landmark FDA approval of dupilumab for COPD.
Dupilumab Becomes First Biologic Approved in the US as Targeted Therapy for Adults with COPD
Dupilumab represents the first new treatment approach for uncontrolled COPD in more than a decade and reduced disease exacerbations by 34% in clinical trials.
FDA Approves First-in-Class Schizophrenia Drug, Described as "Quantum Leap Forward"
Cobenfy, previously KarXT, is the first new agent with a novel mechanism of action for schizophrenia in more than 50 years, according to BMS.
Better CV Health in Early Pregnancy Offsets High Genetic Risk: Daily Dose
Your daily dose of the clinical news you may have missed.
Swelling Behind the Ear: Seen in the ED
A 2-year-old child has had a low-grade fever for 4 days and a swelling has developed behind the left ear. She just recovered from a URI. What's your diagnosis?
7 Drugs Approved for Primary Care: Q3 2024
Updated mRNA COVID-19 vaccines, the first orally disintegrating tablet approved for pregnancy prevention, and 5 more.
Atrial Fibrillation More Prevalent in US Than Previously Estimated: Daily Dose
Cancer Diagnosis Rates in 2021 Still Lagged Behind Projections Following Pandemic Effects
The decline in cancer diagnoses during the COVID-19 shutdown in 2020 did not lead to an expected compensatory increase in diagnoses in 2021, according to NCI researchers.
Lebrikizumab Demonstrates Sustained Disease Control in Atopic Dermatitis Up to 3 Years
Among adolescents and adults with moderate-to-severe AD, more than 80% achieved sustained disease control, the majority not requiring topical or systemic rescue medication.
Roflumilast Cream 0.15% Leads to Consistent Improvements in Atopic Dermatitis Across Diverse Skin Types
Roflumilast cream 0.15% was associated with consistent and meaningful improvements in AD clearance and itch reduction, according to new data.
Preconception Prediabetes Ups Risk for Poor Pregnancy Outcomes in Young Women: New Data
The risk of gestational diabetes was 2-fold greater among young women with prediabetes before conceiving compared with those who had normoglycemia.
Strong Link Between Increasing Lp(a) Level and Recurrent ASCVD Events Makes Screening Essential, Investigator Warns
A continuous increase in ASCVD risk was seen with higher levels of lipoprotein(a) in the largest study to date of the relationship.
Over Half of US Adults with Uncontrolled HTN Unaware of Their Condition: Daily Dose
Resistant & Refractory Hypertension: 9 Questions for Primary Care
How are you managing your patients with resistant or refractory hypertension? How do your strategies align with current guidelines? Try these 9 questions and find out.
Elinzanetant for Menopausal VMS: OASIS Lead Investigator Discusses Results, Side Effects, Next Steps
JoAnn Pinkerton, MD, details the positive findings from the OASIS 1, 2, and 3 studies of elinzanetant and highlights next steps in research.
FDA Accepts NDA for Delgocitinib Cream, Developed Specifically to Treat Chronic Hand Eczema
Delgocitinib specifically inhibits activation of JAK-STAT signaling in chronic hand eczema and would be an option for people unable to use topical corticosteroids.
FDA Approves Lebrikizumab-lbkz for Moderate to Severe AD: Daily Dose
High Percentage of Patients Seek Mental Health Care from PCPs, According to New Large Analysis
One in 9 primary care encounters involved a mental health condition, according to an analysis of over 350 million primary care visits.
COVID-19 Vaccines 2024-2025: Is America Ready and Willing?
COVID-19 vaccine myths of many types remain potent enough to raise public health experts' concerns about Americans' willingness to roll up sleeves this year.
Real-World Study Supports Use of DermaSensor in Primary Care to Differentiate Cancerous and Benign Lesions
The AI-based point-of-care device outperformed clinician standard of care for sensitivity (90% vs 40%) and had a negative predictive value of 98.9%
